News | Page 18 of 18 | Endeavour Vision

Symetis Receives CE Mark Approval for Transfemoral Transcatheter Aortic Heart Valve System ACURATE neo™, and Launches Product With First Commercial Implantations

Symetis Joins Industry Leaders Edwards Lifesciences and Medtronic as Only Companies to Offer Both Transapical and Transfemoral Options for Transcatheter Aortic Heart Valve Delivery LAUSANNE, SWITZERLAND–(Marketwired – Sept. 12, 2014) – Symetis SA, the leading European developer of transcatheter aortic valve implantation (TAVI) systems, announced today the launch of [...]

Endeavour Vision2023-04-12T15:35:06+01:00September 12th, 2014|All News, Company News, Previous Sectors|

Bind Therapeutics enters nanomedicine collaboration with Swiss drug giant

By Chris Reidy | GLOBE STAFF JUNE 19, 2014 – Bind Therapeutics Inc., a Cambridge-based nanomedicine company that is developing programmable drugs to certain types of cancer, said Thursday it has entered into a research agreement with Swiss drug giant Roche to discover novel treatment of diseases in therapeutic [...]

Endeavour Vision2023-04-12T11:19:33+01:00June 19th, 2014|All News, Company News, Previous Sectors|

Roche and Molecular Partners enter into alliance to develop new cancer treatments

Partnership will combine novel biologics (DARPins) with Roche drug-conjugate technology Basel, Switzerland / Zurich-Schlieren, Switzerland, 04 December 2013. Roche (SIX: RO, ROG; OTCQX: RHHBY) and Molecular Partners AG today announced that they have entered into a research collaboration and licensing agreement to discover, develop and commercialize several proprietary therapeutics [...]

Endeavour Vision2023-04-12T13:47:31+01:00December 4th, 2013|All News, Company News, Previous Sectors|

Blackhawk Network Acquires Germany-Based Prepaid Leader Retailo as Part of Ongoing International Expansion Strategy

Blackhawk Network Acquires Germany-Based Prepaid Leader Retailo as Part of Ongoing International Expansion Strategy Deal brings Blackhawk’s retail network to over 40,000 retail locations in world’s 4th largest economy LONDON – Dec. 2, 2013 – Blackhawk Network announced that it has completed the acquisition of Germany-based Retailo AG, [...]

Endeavour Vision2023-04-03T12:51:49+01:00December 2nd, 2013|All News, Company News, Previous Sectors|

Symetis Announces a Symbolic Milestone – the 1000th Patient Implanted with ACURATE TA

ECUBLENS, SWITZERLAND – Oct. 28, 2013 – Symetis Inc., a privately-owned Swiss company focused on transcatheter aortic valve implantation (TAVI) systems announced today that it has achieved a symbolic milestone: the implantation of the 1000th ACURATE TA™ transaortic valve. The first ACURATE TA™ valve was implanted in November 2009 [...]

Endeavour Vision2023-04-12T13:38:34+01:00October 28th, 2013|All News, Company News, Previous Sectors|

CeQur SA names Robert O’Holla EVP for Regulatory Affairs

Former Worldwide VP for Regulatory Affairs at Johnson & Johnson Brings Vast Experience in Medical Device Submissions, Approvals and GMP Compliance. MONTREUX, Switzerland, April 13, 2010 – CeQur SA, a company focused on the development and commercialization of insulin delivery systems to improve the management of type 2 diabetes, [...]

Endeavour Vision2023-04-12T12:59:10+01:00April 13th, 2010|All News, Company News|

BIND Therapeutics Announces Pricing of Initial Public Offering

CAMBRIDGE, Mass. (EON: Enhanced Online News) BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins™, announced today the pricing of its initial public offering of 4,700,000 shares of its common stock at a public offering price of $15.00 per share, before underwriting discounts [...]

Endeavour Vision2023-04-12T11:22:59+01:00September 19th, 2009|All News, Company News, Previous Sectors|